Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Besponsa (Inotuzumab Ozogamicin) Medicine in India

Buy Besponsa (Inotuzumab Ozogamicin) Medicine in India

Besponsa (Inotuzumab Ozogamicin)

Medicine name : Besponsa

Generic name : Inotuzumab Ozogamicin

Manufactured By : Pfizer

Indications : Relapsed or Refractory B-Cell precursor ALL

Medicine Description : Besponsa is an antibody-drug conjugate used for relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It targets CD22 on cancer cells, delivering a cytotoxic agent to induce cell death. Administered via IV infusion, it improves remission rates. Side effects include liver toxicity, low blood counts, and infusion reactions. Patients are closely monitored for veno-occlusive disease (VOD) and liver function.

Product Introduction

Besponsa (Inotuzumab Ozogamicin) is a targeted anticancer treatment used for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-cell precursor ALL). It is a CD22-directed antibody-drug conjugate (ADC) that specifically targets CD22 proteins found on certain leukemia cells, helping deliver the treatment directly to abnormal cells and slow their growth.

Besponsa (Inotuzumab Ozogamicin) is administered by a healthcare professional through an intravenous infusion. The dosage and treatment schedule are determined by the doctor based on the patient's condition and response to treatment. It should be administered only as directed by a healthcare professional. Regular medical consultations and blood tests may be required to monitor treatment response, blood cell counts, and potential side effects.

Common side effects of Besponsa (Inotuzumab Ozogamicin) may include reduced blood cell counts, infections, fatigue, bleeding, fever, nausea, headache, increased liver enzymes, and abdominal pain. Before starting treatment, inform your doctor about any history of bleeding problems, liver or heart conditions, infections, or previous treatments. Tell your doctor about all medicines and supplements you are taking, as drug interactions may occur. Contact your healthcare professional promptly if you experience unusual bleeding or bruising, dark or bloody stools, fever, sore throat, or other signs of infection. Effective contraception is recommended for both males and females during treatment to help prevent pregnancy.

Uses Of Besponsa (Inotuzumab Ozogamicin)

Treatment of Acute Lymphoblastic Leukemia

Benefits Of Besponsa

Besponsa (Inotuzumab Ozogamicin) is used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). It is a targeted cancer treatment that binds to CD22 proteins present on certain leukemia cells and helps deliver the active drug to these abnormal cells. This helps destroy leukemia cells and slow the progression of the disease. Discuss the potential benefits and risks of treatment with your doctor and follow all medical advice throughout therapy.

Side Effects Of Besponsa (Inotuzumab Ozogamicin)

Most side effects of Besponsa (Inotuzumab Ozogamicin) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Besponsa (Inotuzumab Ozogamicin)

  • Low blood platelets
  • Decreased white blood cell count
  • Infection
  • Anemia
  • Fatigue
  • Hemorrhage
  • Fever
  • Nausea
  • Headache
  • Abdominal pain
How To Use Besponsa

Besponsa (Inotuzumab Ozogamicin) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your condition, treatment response, and overall health. It should only be administered under medical supervision, and regular blood tests and other monitoring may be required during treatment.

How Besponsa (Inotuzumab Ozogamicin) Works

Besponsa (Inotuzumab Ozogamicin) is an antineoplastic treatment used for adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL). It targets the CD22 antigen found on immature B-cell lymphocytes and delivers its active component to these abnormal cells, helping to destroy leukemia cells and inhibit their growth. This treatment may help improve blood cell counts and support the achievement of complete remission in eligible patients.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

There is limited information about alcohol use with Besponsa (Inotuzumab Ozogamicin). Speak with your doctor before consuming alcohol during treatment.

PregnancyCONSULT YOUR DOCTOR

Besponsa (Inotuzumab Ozogamicin) may cause harm to an unborn baby and is generally not recommended during pregnancy. Your doctor will carefully consider the potential benefits and risks before starting treatment.

BreastfeedingCONSULT YOUR DOCTOR

It is not known whether Besponsa (Inotuzumab Ozogamicin) passes into human breast milk. Breastfeeding may not be recommended during treatment. Consult your doctor for appropriate guidance.

DrivingCONSULT YOUR DOCTOR

Besponsa (Inotuzumab Ozogamicin) may cause dizziness, fatigue, or other effects that can reduce alertness. Avoid driving or operating machinery if you experience these symptoms.

KidneyCAUTION

Tell your doctor if you have kidney disease before receiving Besponsa (Inotuzumab Ozogamicin). Patients with severe kidney problems may require careful monitoring and medical supervision.

LiverCAUTION

Inform your doctor about any liver condition before starting Besponsa (Inotuzumab Ozogamicin). Liver function may be monitored during treatment, particularly because this treatment can affect liver health.

Quick Tips
  • Your doctor may regularly check your blood counts and liver function before and during treatment with Besponsa (Inotuzumab Ozogamicin).
  • Use effective contraception during treatment. Males should continue contraception for at least 5 months and females for at least 8 months after the final dose.
  • Avoid breastfeeding during treatment with Besponsa (Inotuzumab Ozogamicin) and for 2 months after the last dose.
  • Besponsa (Inotuzumab Ozogamicin) may cause dizziness. Rise slowly when getting up after sitting or lying down.
  • Treatment may increase the risk of infections. Avoid close contact with people who are unwell and contact your doctor promptly if you develop fever or other signs of infection.
  • Read More About - Besponsa (Inotuzumab Ozogamicin) from Pharma Five.
Faq

General Question

Besponsa (Inotuzumab Ozogamicin) is a prescription cancer medication used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-ALL).

Besponsa is an antibody-drug conjugate. It targets the CD22 protein on cancer cells and delivers a toxin directly to those cells, helping to kill them while sparing most healthy cells.

Besponsa is prescribed to adults with B-cell ALL who have not responded to or have relapsed after previous treatments.

Besponsa is given by intravenous (IV) infusion in cycles, usually once a week for 3 weeks in a 21- to 28-day cycle, under the supervision of a healthcare professional.

Common side effects include fatigue, nausea, headache, fever, low blood cell counts, and increased risk of infections.

Yes, Besponsa may cause serious side effects such as liver damage (including veno-occlusive disease), low blood counts, infections, and infusion-related reactions. Inform your doctor if you notice yellowing of the skin, swelling, or breathing difficulties.

The treatment duration depends on how you respond and how well you tolerate the medicine. Your doctor will determine the number of cycles needed.

It is best to avoid alcohol while on Besponsa, as it may increase the risk of liver damage and intensify side effects.

No, Besponsa may harm an unborn baby. Women should use effective contraception during treatment and for some time after the last dose.

Yes, Besponsa can interact with other drugs. Inform your doctor about all medications, including over-the-counter drugs and supplements.

Besponsa is administered in a clinical setting, so your healthcare provider will manage missed doses or rescheduling.

Besponsa is given via IV, so it is not affected by food intake.

Have regular blood tests to monitor liver function and blood counts, avoid infection exposure, and report any unusual symptoms like abdominal pain, weight gain, or jaundice.

Besponsa is stored and handled by healthcare professionals in hospitals or infusion centers.

Besponsa is available by prescription and is administered in specialized medical facilities. Speak with your oncologist for access and treatment planning. Pharma Five assists in its procurement.